SI1216038T1 - Ramipril za preprecevanje kardiovaskularnih dogodkov - Google Patents

Ramipril za preprecevanje kardiovaskularnih dogodkov

Info

Publication number
SI1216038T1
SI1216038T1 SI200030762T SI200030762T SI1216038T1 SI 1216038 T1 SI1216038 T1 SI 1216038T1 SI 200030762 T SI200030762 T SI 200030762T SI 200030762 T SI200030762 T SI 200030762T SI 1216038 T1 SI1216038 T1 SI 1216038T1
Authority
SI
Slovenia
Prior art keywords
ramipril
prevention
cardiovascular events
cardiovascular
events
Prior art date
Application number
SI200030762T
Other languages
English (en)
Inventor
Bernward Schoelkens
Norbert Bender
Badrudin Rangoonwala
Salim Yusuf
Hertzel Gerstein
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Priority claimed from PCT/EP2000/008461 external-priority patent/WO2001015674A2/en
Publication of SI1216038T1 publication Critical patent/SI1216038T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI200030762T 1999-08-30 2000-08-30 Ramipril za preprecevanje kardiovaskularnih dogodkov SI1216038T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15143699P 1999-08-30 1999-08-30
PCT/EP2000/008461 WO2001015674A2 (en) 1999-08-30 2000-08-30 Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events
EP00965906A EP1216038B1 (en) 1999-08-30 2000-08-30 Ramipril for the prevention of cardiovascular events

Publications (1)

Publication Number Publication Date
SI1216038T1 true SI1216038T1 (sl) 2006-02-28

Family

ID=35463995

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200030762T SI1216038T1 (sl) 1999-08-30 2000-08-30 Ramipril za preprecevanje kardiovaskularnih dogodkov

Country Status (2)

Country Link
EP (1) EP1611886A3 (sl)
SI (1) SI1216038T1 (sl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2690741T3 (es) 2009-02-11 2018-11-22 Cadila Pharmaceuticals Ltd. Composición farmacéutica estable para la aterosclerosis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3226768A1 (de) * 1981-11-05 1983-05-26 Hoechst Ag, 6230 Frankfurt Derivate der cis, endo-2-azabicyclo-(3.3.0)-octan-3-carbonsaeure, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung
ZA896851B (en) * 1988-09-14 1990-06-27 Hoffmann La Roche Use of ace-inhibitors
US5190970A (en) * 1990-10-19 1993-03-02 E. R. Squibb & Sons, Inc. Method for preventing onset of or treating Type II diabetes employing a cholesterol lowering drug alone or in combination with an ace inhibitor

Also Published As

Publication number Publication date
EP1611886A3 (en) 2008-06-04
EP1611886A2 (en) 2006-01-04

Similar Documents

Publication Publication Date Title
GB2361186B (en) Formulation for the prevention of cardiovascular disease
PL346237A1 (en) Sethod for the preparation of citalopram
HUP0104218A3 (en) New esters derived from substituted phenyl-cyclohexyl compounds
GB9924797D0 (en) Compound
AU4477700A (en) Licensed band adaptations
IL148640A0 (en) Processes for the preparation of sumatriptan and related compounds
GB9920919D0 (en) Novel compound
SI1216038T1 (sl) Ramipril za preprecevanje kardiovaskularnih dogodkov
GB2389113B (en) B-secretase inhibitor
GB9921928D0 (en) Compound
GB0031557D0 (en) Compound
GB0031563D0 (en) Compound
GB9914342D0 (en) Compound
GB9921929D0 (en) Compound
GB9929255D0 (en) Compound
AU3894500A (en) Prevention of cardiovascular disease
EP1209240A4 (en) CONNECTION F-15078
TW388465U (en) Fastening nut
IL144719A0 (en) Method for the prevention or reduction of cardiovascular events associated with coronary intervention
HU0000970D0 (en) Rapid fastening set
TW371938U (en) Improvement of the basket
GB9924965D0 (en) Compound
AU145113S (en) Flange
GB2356421B (en) Manufacture of timber components
IL144721A0 (en) Method for the prevention or reduction of cardiovascular events associated with coronary intervention